These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16039122)

  • 61. 4-(Pyrrolidinyl)methoxybenzoic acid derivatives as a potent, orally active VLA-4 antagonist.
    Chiba J; Iimura S; Yoneda Y; Sugimoto Y; Horiuchi T; Muro F; Ochiai Y; Ogasawara T; Tsubokawa M; Iigou Y; Takayama G; Taira T; Takata Y; Yokoyama M; Takashi T; Nakayama A; Machinaga N
    Chem Pharm Bull (Tokyo); 2006 Nov; 54(11):1515-29. PubMed ID: 17077548
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Melanoma cell adhesion can be blocked by heparin in vitro: suggestion of VLA-4 as a novel target for antimetastatic approaches.
    Fritzsche J; Simonis D; Bendas G
    Thromb Haemost; 2008 Dec; 100(6):1166-75. PubMed ID: 19132244
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Design, synthesis, and structure-activity relationships of piperidine and dehydropiperidine carboxylic acids as novel, potent dual PPARalpha/gamma agonists.
    Ye XY; Li YX; Farrelly D; Flynn N; Gu L; Locke KT; Lippy J; O'Malley K; Twamley C; Zhang L; Ryono DE; Zahler R; Hariharan N; Cheng PT
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3545-50. PubMed ID: 18511276
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Alpha4beta1 integrin blockade after spinal cord injury decreases damage and improves neurological function.
    Fleming JC; Bao F; Chen Y; Hamilton EF; Relton JK; Weaver LC
    Exp Neurol; 2008 Dec; 214(2):147-59. PubMed ID: 19038604
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Selectively targeting T- and B-cell lymphomas: a benzothiazole antagonist of alpha4beta1 integrin.
    Carpenter RD; Andrei M; Aina OH; Lau EY; Lightstone FC; Liu R; Lam KS; Kurth MJ
    J Med Chem; 2009 Jan; 52(1):14-9. PubMed ID: 19072684
    [TBL] [Abstract][Full Text] [Related]  

  • 66. N-isonicotinoyl-(L)-4-aminophenylalanine derivatives as tight binding VLA-4 antagonists.
    Doherty GA; Yang GX; Borges E; Tong S; McCauley ED; Treonz KM; Van Riper G; Pacholok S; Si Q; Koo GC; Shah K; Mumford RA; Hagmann WK
    Bioorg Med Chem Lett; 2003 Jun; 13(11):1891-5. PubMed ID: 12749892
    [TBL] [Abstract][Full Text] [Related]  

  • 67. N-(pyrimidin-4-yl) and N-(pyridin-2-yl) phenylalanine derivatives as VLA-4 integrin antagonists.
    Porter JR; Archibald SC; Brown JA; Childs K; Critchley D; Head JC; Hutchinson B; Parton TA; Robinson MK; Shock A; Warrellow GJ; Zomaya A
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1595-8. PubMed ID: 12039570
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthesis of some new 2-(6-methoxy-2-naphthyl)- 5-aryl-1,3,4-oxadiazoles as possible non-steroidal anti-inflammatory and analgesic agents.
    Narayana B; Vijaya Raj KK; Ashalatha BV; Kumari NS
    Arch Pharm (Weinheim); 2005 Aug; 338(8):373-7. PubMed ID: 16041838
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis of novel 1,3,4-oxadiazole derivatives and their biological properties.
    Husain A; Ajmal M
    Acta Pharm; 2009 Jun; 59(2):223-33. PubMed ID: 19564146
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rational design of potent and selective VLA-4 inhibitors and their utility in the treatment of asthma.
    Singh J; Adams S; Carter MB; Cuervo H; Lee WC; Lobb RR; Pepinsky RB; Petter R; Scott D
    Curr Top Med Chem; 2004; 4(14):1497-507. PubMed ID: 15544540
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of the pharmacology of hydroxamate- and carboxylate-based matrix metalloproteinase inhibitors (MMPIs) for the treatment of osteoarthritis.
    Janusz MJ; Hookfin EB; Brown KK; Hsieh LC; Heitmeyer SA; Taiwo YO; Natchus MG; Pikul S; Almstead NG; De B; Peng SX; Baker TR; Patel V
    Inflamm Res; 2006 Feb; 55(2):60-5. PubMed ID: 16612565
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Synthesis of sialic acid derivatives as ligands for the myelin-associated glycoprotein (MAG).
    Shelke SV; Gao GP; Mesch S; Gäthje H; Kelm S; Schwardt O; Ernst B
    Bioorg Med Chem; 2007 Jul; 15(14):4951-65. PubMed ID: 17507233
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effect of a single inhaled dose of a VLA-4 antagonist on allergen-induced airway responses and airway inflammation in patients with asthma.
    Ravensberg AJ; Luijk B; Westers P; Hiemstra PS; Sterk PJ; Lammers JW; Rabe KF
    Allergy; 2006 Sep; 61(9):1097-103. PubMed ID: 16918513
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 2,3-Diphenylpropionic acids as potent VLA-4 antagonists.
    Hoshina Y; Ikegami S; Okuyama A; Fukui H; Inoguchi K; Maruyama T; Fujimoto K; Matsumura Y; Aoyama A; Harada T; Tanaka H; Nakamura T
    Bioorg Med Chem Lett; 2005 Jan; 15(1):217-20. PubMed ID: 15582442
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Further optimization of sulfonamide analogs as EP1 receptor antagonists: synthesis and evaluation of bioisosteres for the carboxylic acid group.
    Naganawa A; Matsui T; Ima M; Saito T; Murota M; Aratani Y; Kijima H; Yamamoto H; Maruyama T; Ohuchida S; Nakai H; Toda M
    Bioorg Med Chem; 2006 Nov; 14(21):7121-37. PubMed ID: 16879970
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Marked strain differences in the pharmacokinetics of an alpha4beta1 integrin antagonist, 4-[1-[3-Chloro-4-[N-(2-methylphenyl)-ureido]phenylacetyl]-(4S)-fluoro-(2S)-pyrrolidine-2-yl]-methoxybenzoic Acid (D01-4582), in Sprague-Dawley rats are associated with albumin genetic polymorphism.
    Ito T; Takahashi M; Sudo K; Sugiyama Y
    J Pharmacol Exp Ther; 2007 Jan; 320(1):124-32. PubMed ID: 17038508
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis and evaluation of some novel isochroman carboxylic acid derivatives as potential anti-diabetic agents.
    Lakshminarayana N; Rajendra Prasad Y; Gharat L; Thomas A; Ravikumar P; Narayanan S; Srinivasan CV; Gopalan B
    Eur J Med Chem; 2009 Aug; 44(8):3147-57. PubMed ID: 19349096
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: use of cyclopentane and cyclopentene P2-motifs.
    Bäck M; Johansson PO; Wångsell F; Thorstensson F; Kvarnström I; Ayesa S; Wähling H; Pelcman M; Jansson K; Lindström S; Wallberg H; Classon B; Rydergård C; Vrang L; Hamelink E; Hallberg A; Rosenquist S; Samuelsson B
    Bioorg Med Chem; 2007 Nov; 15(22):7184-202. PubMed ID: 17845856
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aroylpropionic acid based 2,5-disubstituted-1,3,4-oxadiazoles: synthesis and their anti-inflammatory and analgesic activities.
    Akhter M; Husain A; Azad B; Ajmal M
    Eur J Med Chem; 2009 Jun; 44(6):2372-8. PubMed ID: 18977556
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Discovery and evaluation of N-(triazin-1,3,5-yl) phenylalanine derivatives as VLA-4 integrin antagonists.
    Porter JR; Archibald SC; Brown JA; Childs K; Critchley D; Head JC; Hutchinson B; Parton TA; Robinson MK; Shock A; Warrellow GJ; Zomaya A
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1591-4. PubMed ID: 12039569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.